Relationship between lung function and blood pressure in Chinese men and women of Beijing and Guangzhou

International Journal of Epidemiology

Volumn 27, Issue 1, 1998, Pages 49-56

  Wu, Yangfeng ^a   Vollmer, William M ^b   Buist, A Sonia ^c   Tsai, Rusheng ^a   Cen, Runchao ^d   Wu, Xigui ^a   Chen, Peifang ^d   Li, Yao ^a   Guo, Chenye ^d   Mai, Jianzhuang ^d   Davis, C E ^e   Irving, Sandra H ^f  

^a FUWAI HOSPITAL   (China)

^b KAISER PERMANENTE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Guangdong Provincial Cardiovascular Institute   (China)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f IL   (United States)

Author keywords

Blood pressure; China; Lung function

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CHINESE; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; EDUCATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; HYPERTENSION; INCIDENCE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RURAL AREA; SMOKING; SYSTOLIC BLOOD PRESSURE; URBAN AREA; VITAL CAPACITY;

ADULT; AGE DISTRIBUTION; BLOOD PRESSURE DETERMINATION; CHINA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEX DISTRIBUTION;

EID: 15444339304     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/27.1.49     Document Type: Article

References (41)

1. Peabody FW, Wentworth JA. Clinical studies of the respiration IV. The vital capacity of the lung and its relation to dysnea. Arch Intern Med 1917;20:483-98.
2. Peters JP Jr, Barr DP. Studies of the respiratory mechanism in cardic dysnea II. A note on the effective lung volume in cardiac dysnea. Am J Physiol 1920;335-44.
3. Friedman GD, Klatsky AL, Siegelaub MS. Lung function and risk of myocardial infarction and sudden death. N Engl J Med 1976;294: 1071-75.
4. Marcus EB, Curb JD, Maclean CI, Reed DM, Yano K. Pulmonary function as a predictor of coronary heart disease. Am J Epidemiol 1989;129:97-104.
5. Kannel WB, Hubert H, Lew EA. Vital capacity as a predictor of cardiovascular disease: Framingham Study. Am Heart J 1983;105:311-15.
6. Persson C, Bengtsson C, Lapidus L, Rybo E, Thiringer G, Wedel H. Peak respiratory flow and risk of cardiovascular disease and death. Am J Epidemiol 1986;124:942-48.
7. Keys A, Aravanis C, Blackburn H et al. Lung function as a risk factor for coronary heart disease. Am J Public Health 1972;62:1506-11.
8. Weiss ST. Pulmonary function as a phenotype physiologic marker of cardiovascular morbidity and mortality. Chest 1991;99:265-66.
9. Higgins M, Keller JB, Wagenknecht LE et al. Pulmonary function and cardiovascular risk factor relationships in black and in white young men and women: The CARDIA Study. Chest 1991;99:315-22.
10. Walker M, Shaper AG, Phillips AN, Cook DG. Short stature, lung function and risk of a heart attack. Int J Epidemiol 1989;18:602-06.
11. Cook DG, Shaper AG. Breathlessness, lung function and the risk of heart attack. Eur Heart J 1988;9:1215-22.
12. Schlesinger Z, Goldbourt U, Medalie JH, Neufeld N, Risse E, Oron D. Ischemic heart disease and pulmonary ventilatory function. Isr J Med Sci 1975;11:308-13.
13. Kannel WB, Seidman JM, Fercho W, Castelli WP. Vital capacity and congestive heart failure: The Framingham Study. Circulation 1974; 49:1160-66.
14. Sparrow D, Weiss ST, Vokonas PS, Cupples LA, Ekerdt DJ, Colton T. Forced vital capacity and the risk of hypertension: The Normative Aging Study. Am J Epidemiol 1988;127:734-41.
15. Selby JV, Friedman GD, Quesenberry CP. Precursors of essential hypertension: Pulmonary function, heart rate, uric acid, serum cholesterol and other serum chemistries. Am J Epidemiol 1990;131:1017-27.
16. Masaki KH, Rodriguez BL, Burchfiel CM et al. Pulmonary function decline and 18-year coronary heart disease mortality: The Honolulu Heart Program. Abstract Book, 3rd International Conference on Preventive Cardiology, Oslo, Norway. 1993;42.
17. Lange P, Nyboe J, Jensen G, Schnor P, Appleyard M. Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. Eur Respir J 1991;4:1080-87.
18. Higgins MW, Keller JB. Predictors of mortality in the adult population of Tecumseh. Arch Environ Health 1970;21:418-24.
19. Cullen K, Stenhouse NS, Wearne KL, Welborn TA. Multiple regression analysis of risk factor for cardiovascular disease and cancer mortality in Busselton, Western Australia: 13 year study. J Chron Dis 1983; 36:371-77.
20. Ebi-Kryston KL. Respiratory symptoms and pulmonary function as predictors of 10 year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall study. J Clin Epidemiol 1988; 41:251-60.
21. Ebi-Kryston KL, Hawthorne VM, Rose G et al. Breathlessness, chronic bronchitis and reduced pulmonary function as predictors of cardiovascular disease mortality among men in England, Scotland and the United States. Int J Epidemiol 1989;18:84-88.
22. Epstein FH, Francis T Jr, Hayner NS et al. Prevalence of chronic diseases and distribution of selected physiologic variables in a total community, Tecumseh, Michigan. Am J Epidemiol 1965;81:307-22.
23. Benfante R, Reed D, Brody J. Biological and social predictors of health in an aging cohort. J Chronic Dis 1985;38:385-95.
24. PRC-USA Cardiovascular and Cardiopulmonary Epidemiology Research Group. An epidemiologic study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People's Republic of China: Baseline report from the PRC-USA Collaborative Study. Circulation 1992;85:1083-96.
25. Tao S, Li Y, Xiao Z et al. Serum lipids and their correlates in Chinese urban and rural populations of Beijing and Guangzhou. Int J Epidemiol 1992;21:893-903.
26. US Department of Health and Human Services. Data preview from the People's Republic of China: Data from USA-PRC Collaborative Study of Cardiovascular and Cardiopulmonary Epidemiology. Background. Public Health Service, National Institutes of Health, Bethesda, MD, 1989.
27. US Department of Health and Human Services. Data preview from the People's Republic of China: Data from USA-PRC Collaborative Study of Cardiovascular and Cardiopulmonary Epidemiology. Baseline Pulmonary Function. Public Health Service, National Institutes of Health, Bethesda, MD, 1989.
28. American Thoracic Society Statement: Standardization of spirometry - 1987 update. Am Rev Respir Dis 1987;136:1285-98.
29. Buist AS, Vollmer WM, Wu Y et al. Effects of cigarette smoking in lung function in four population samples in the People's Republic of China. Am J Respir Crit Care Med 1995;151:1393-400.
30. Kleinbaum D, Kupper L, Morgenstern H. Epidemiologic Research. Van Nostrand Reinhold Company, Inc., New York, 1982.
31. Cohen BH. Is pulmonary disfunction the common denominator for the multiple effects of cigarette smoking? Lancet 1978;ii:1024-27.
32. Stamler R, Liu L, Nichols R et al. Blood pressure and life style in the People's Republic of China: three samples in the INTERSALT study. J Hum Hypertens 1993;7:429-35.
33. Wu X, Huang Z, Stamler J et al. Changes of average blood pressure (systolic, diastolic) and incidence of high blood pressure, 1983-4 to 1987-8, four population cohorts, People's Republic of China. J Hypertens 1996;14:1267-74.
34. Wu X, Zhou B, Tao S, Zhang H, Wu Y. The incidence of hypertension and associated factors in 10 populations of China. Chin Med Sci J 1991;6(Suppl.):19.
35. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
36. Modan M, Halkin H, Almog S et al. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985;75: 809-17.
37. Manolio TA, Savage PT, Burke GL et al. Association of fasting insulin with blood pressure and lipids in young adults: the CARDIA Study. Arteriosclerosis 1990;10:430-36.
38. DeFronzo RA, Ferrannini E. Insulin resistance: a Multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diab Care 1991;14:173-94.
39. Seidell JC, Cigolini M, Charzewska J et al. Indicators of fat distribution, serum lipids, and blood pressure in European women born in 1984 - The European Fat Distribution Study. Am J Epidemiol 1989:130: 53-65.
40. Folsom AR, Burke GL, Ballew C et al. Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites: The role of insulin. Am J Epidemiol 1989;130:911-24.
41. Folsom AR, Li Y, Rao X et al. Body mass, fat distribution and cardiovascular risk factors in a lean population of south China. J Clin Epidemiol 1994;47:173-81.